Control Bionics Ltd - CBL share price
About Control Bionics Ltd
Control Bionics Ltd is an Australia-based company that designs, manufactures and sells wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology products. The Company’s products are NeuroNode 3 and NeuroNode Trilogy and NeuroNode GridPad Trilogy. The Company’s products allows users to operate and communicate via a computer using intentional thought and the body’s own neuroelectric signals transmitted to skeletal muscle sites. The physical movement of a muscle is not necessary for the technology to detect a signal or interface with a device. The Company is specialized in the field of neuroelectric control as the technology uses smart algorithms to detect, synthesize and convert EMG signals into code which can interface with and control a broad range of electronic devices. NeuroNode 3 is capable of executing tasks on a device that normally are completed by able bodied users with a keyboard, mouse or touch screen.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Try Veye Free for 7 Days
Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.
No credit card required
Price Chart (CBL)
TOP ASX STOCKS Worth Watching
- ✓ Instant Access
- ✓ No Credit Card Required
- ✓ Free to join · No spam
Free to join · No spam · Unsubscribe anytime
By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.
Discover the Top ASX Stocks to Invest in 2026!
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Other Reports from Veye
Latest Article